Disparities across the globe continue to surface as we approach year 2 of the COVID-19 pandemic, especially in health care. As one considers its implications, a research team from the American Cancer Society investigated its potential impact on early cancer detection.
Unemployment rates hit a record high in April of 2020 as the largest 1-month increase in history1, and quickly caught up to rates seen during the Great Depression.2 With employers as the most common source of health insurance among adults, these rates were undoubtedly worrisome. What might the implications of the pandemic be on early cancer detection? Did loss of employment impact the public’s access to cancer screening?
Researchers from the American Cancer Society (ACS) searched for the answers. Their findings were published online today in the peer-reviewed journal Cancer.3
Using data from 2000-2018 National Health Interview Survey, an ACS research team investigated potential relationships between unemployment, health insurance, and cancer screening among nonelderly adults (under age 65) in the United States. They concluded that unemployment, thereby a lack of health insurance, was directly related to the low screening rates.
The team used survey data to compute up-to-date and past-year breast, cervical, colorectal, and prostate cancer screening prevalence among nonelderly respondents. They used multivariable logistic regression models with marginal probabilities to estimate unemployed versus employed unadjusted and adjusted prevalence ratios.
Unemployed adults were 4 times less likely to have health insurance than employed adults (41.4% vs 10.0%, P<.001) and had significantly lower up-to-date prevalence of all cancer screenings: cervical (78.5% vs 86.2%; P < .001), breast (67.8% vs 77.5%; P < .001), colorectal (41.9 vs 48.5%; P < .001), and prostate (25.4% vs 36.4%; P < .001). Researchers noted that these differences were eliminated after accounting for health insurance coverage.
Unemployed adults were also less likely to be up to date with their long-term screenings. “This suggests that being unemployed at a single point in time may hinder both recent and potentially longer-term screening practices,” researcher Stacy Fedewa, PhD, said in a press release.4
The findings are critical because outdated or missed cancer screenings can increase a person’s risk of being diagnosed with late-stage cancer, which is more difficult to treat than cancer detected at an early stage.
“Our finding that insurance coverage fully accounted for unemployed adults’ lower cancer screening utilization is potentially good news, because it’s modifiable,” Fedewa added.
The research team concluded that, by ensuring the continuation of health insurance coverage after a job loss, we may be able to mitigate the pandemic’s economic distress and reduce any future economic downturns’ impact on cancer screening.
The study indicates a need for health insurance offerings to include all people regardless of employment status.
References
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More